Alexandra Gallo-Cook
- Currently representing a New England-based mutual insurance company in a bad faith claim case pending in Rhode Island State Court.
- Served on trial team in federal antitrust jury trial of a nationwide class action alleging global price fixing in sales of capacitors.
- Represented Qiagen N.V. as part of the antitrust counsel team in its $11 billion sale to Thermo Fisher Scientific, announced in March 2020.
- Successfully defended Neurotrope Biotechnology Inc in a securities class action case, achieving a complete victory at the motion to dismiss stage.
- Served as lead trial counsel in arbitration proceedings, obtaining full dismissal of all charges against professional sports team in a matter alleging variety of contract and tort claims.
- Obtained full dismissal on motion to dismiss in real estate matter pending in New York Supreme Court.
- Represented international client, successfully obtaining determination by International Trade Commission, later affirmed by the Federal Circuit, barring importation of infringing products.
- Obtained summary judgment in favor of commercial client in a contract dispute in New York State Court.
Case Study
Mintz secured dismissal of a securities fraud case against biopharmaceutical company Neurotrope. Mintz argued that securities laws do not require disclosure of the statistical methodology behind announced clinical trial results.